Novo Nordisk patent expiry opens door to cheaper weight-loss drugs in India - Reuters

Novo Nordisk patent expiry opens door to cheaper weight-loss drugs in India  ReutersOzempic, Wegovy: India's cheap weight-loss drugs could reshape global obesity fight  BBCSemaglutide Patent Expires: Will Diabetes, Weight-Loss Treatment Become More Accessible For Patients?  NDTVTsunami of weight-loss drugs to take over India today  India TodayThe weight is over. This injectable fits the bill  The Economic Times